MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 17 filers reported holding MOLECULIN BIOTECH INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $234,000 | +21.2% | 294,513 | +23.4% | 0.00% | – |
| Q3 2020 | $193,000 | -11.9% | 238,686 | +5.0% | 0.00% | – |
| Q2 2020 | $219,000 | +184.4% | 227,313 | +79.7% | 0.00% | – |
| Q1 2020 | $77,000 | -66.5% | 126,497 | -50.0% | 0.00% | – |
| Q4 2019 | $230,000 | +64.3% | 252,994 | +100.0% | 0.00% | – |
| Q3 2019 | $140,000 | -11.4% | 126,497 | 0.0% | 0.00% | – |
| Q2 2019 | $158,000 | +54.9% | 126,497 | 0.0% | 0.00% | – |
| Q1 2019 | $102,000 | -61.1% | 126,497 | -50.0% | 0.00% | – |
| Q4 2018 | $262,000 | +29.7% | 252,994 | +100.0% | 0.00% | – |
| Q3 2018 | $202,000 | -10.6% | 126,497 | 0.0% | 0.00% | – |
| Q2 2018 | $226,000 | +46.8% | 126,497 | +47.8% | 0.00% | – |
| Q1 2018 | $154,000 | -3.1% | 85,590 | 0.0% | 0.00% | – |
| Q4 2017 | $159,000 | +13.6% | 85,590 | +45.3% | 0.00% | – |
| Q3 2017 | $140,000 | +27.3% | 58,888 | 0.0% | 0.00% | – |
| Q2 2017 | $110,000 | – | 58,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 1,600 | $9,000 | 0.01% |
| Virtu KCG Holdings LLC | 11,614 | $66,000 | 0.00% |
| ING GROEP NV | 20,000 | $122,000 | 0.00% |
| NEXT Financial Group, Inc | 500 | $3,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 917 | $5,000 | 0.00% |
| CITIGROUP INC | 5,000 | $29,000 | 0.00% |
| MORGAN STANLEY | 700 | $4,000 | 0.00% |
| WFG Advisors, LP | 400 | $2,000 | 0.00% |
| UBS Group AG | 2,495 | $14,000 | 0.00% |